JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB91102

Native Human IgG protein

Be the first to review this product! Submit a review

|

(11 Publications)

Native Human IgG protein is a Human Full Length protein with >95% purity and suitable for SDS-PAGE.. The predicted molecular weight of ab91102 native protein is 150 kDa

- Save time and ensure accurate results - use our IgG protein as an isotype control
- No cross-reaction from other immunoglobulin isotypes

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

1 Images
SDS-PAGE - Native Human IgG protein (AB91102)
  • SDS-PAGE

Unknown

SDS-PAGE - Native Human IgG protein (AB91102)

SDS-PAGE : 4-12% Bis-Tris NuPAGE gel
Lane 1. Molecular weight markers
Lane 2. 5 μg IgG (reduced/heated)
Lane 3. 10 μg IgG (reduced/heated)
Lane 4. 20 μg IgG (reduced/heated)
Lane 5. 5 μg IgG (non-reduced/no heat)
Lane 6. 10 μg IgG non-reduced/no heat)
Lane 7. 20 μg IgG non-reduced/no heat)

Key facts

Purity

>95% SDS-PAGE

Expression system

Native

Tags

Tag free

Applications

SDS-PAGE

applications

Biologically active

No

Accession

P01857

Animal free

No

Carrier free

No

Species

Human

Reconstitution

Reconstitute first with de-ionized H₂O to the original concentration (See Technical Support) followed by gentle mixing to ensure adequate homogenization. If further dilution is needed, please use the lyophilization buffer (20 mM phosphate buffer, pH 7.4, containing 150 mM NaCl and 0.05% sodium azide).

Storage buffer

pH: 7.4 Preservative: 0.05% Sodium azide Constituents: Phosphate Buffer, 0.87% Sodium chloride

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

The Native Human IgG protein ab91102 is prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

Ensure the validity of your result using our native human Immunoglobulin G (IgG) protein as a control in SDS-PAGE.

Check out our protein gel staining guide for SDS-PAGE here

Protein Determination: Extinction Coefficient (ε) 0.1% at 280 nm, 1 cm pathway = 1.36

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"150 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Native","expressionSystem":null,"accessionNumber":"P01857","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
False

Specifications

Form

Lyophilized

General info

Function

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.

Post-translational modifications

Glycosylation on Asn-180 is required for interaction with Fc receptors and ability to activate the complement pathway.. (Microbial infection) Deglycosylation on Asn-180 by S.pyogenes EndoS or Endos2 endoglucosidases prevents interaction between immunoglobulin-gamma (IgG) and Fc receptors, impairing ability to activate the complement pathway.

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Additional targets

IGHG2,IGHG4,IGHG3

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Journal of asthma and allergy 17:833-845 PubMed39281094

2024

Prevalence and Clinical Relevance of Anti-FcεRI Autoantibody in Crohn's Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Yin,Yusen Hu,Yanning Li,Xia Peng,Huanjin Liao,Wei Shen,Li Li

Clinical cancer research : an official journal of the American Association for Cancer Research 30:1009-1021 PubMed38109209

2023

CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma.

Applications

Unspecified application

Species

Unspecified reactive species

Anju Wadhwa,Sinan Wang,Bonell Patiño-Escobar,Anil P Bidkar,Kondapa Naidu Bobba,Emily Chan,Niranjan Meher,Scott Bidlingmaier,Yang Su,Suchi Dhrona,Huimin Geng,Vishesh Sarin,Henry F VanBrocklin,David M Wilson,Jiang He,Li Zhang,Veronica Steri,Sandy W Wong,Thomas G Martin,Youngho Seo,Bin Liu,Arun P Wiita,Robert R Flavell

Scientific reports 13:17820 PubMed37857783

2023

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2.

Applications

Unspecified application

Species

Unspecified reactive species

Ericka Kirkpatrick Roubidoux,Pamela H Brigleb,Kasi Vegesana,Aisha Souquette,Kendall Whitt,Pamela Freiden,Amanda Green,Paul G Thomas,Maureen A McGargill,Joshua Wolf,Stacey Schultz-Cherry

Journal of human lactation : official journal of International Lactation Consultant Association 37:492-498 PubMed34297643

2021

SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.

Applications

Unspecified application

Species

Unspecified reactive species

Jill K Baird,Shawn M Jensen,Walter J Urba,Bernard A Fox,Jason R Baird

Viruses 13: PubMed34372525

2021

Evaluation of ELISA-Based Multiplex Peptides for the Detection of Human Serum Antibodies Induced by Zika Virus Infection across Various Countries.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Del Pilar Martinez Viedma,Stephen Panossian,Kennedy Gifford,Kimberly García,Isis Figueroa,Leda Parham,Laise de Moraes,Lillian Nunes Gomes,Tamara García-Salum,Cecilia Perret,Daniela Weiskopf,Gene S Tan,Antônio Augusto Silva,Viviane Boaventura,Guillermo M Ruiz-Palacios,Alessandro Sette,Aruna Dharshan De Silva,Rafael A Medina,Ivette Lorenzana,Kevan M Akrami,Ricardo Khouri,Daniel Olson,Brett E Pickett

F1000Research 8:1875 PubMed32201571

2019

Peptide arrays incubated with three collections of human sera from patients infected with mosquito-borne viruses.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Del Pilar Martinez Viedma,Nurgun Kose,Leda Parham,Angel Balmaseda,Guillermina Kuan,Ivette Lorenzana,Eva Harris,James E Crowe,Brett E Pickett

Nanoscale 11:14010-14015 PubMed31309963

2019

Analyte-induced disruption of luminescence quenching (AIDLuQ) for femtomolar detection of biomarkers.

Applications

Unspecified application

Species

Unspecified reactive species

Bipin Sharma,Shailendra Chiluwal,Ramakrishna Podila

Maternal health, neonatology and perinatology 5:9 PubMed31205733

2019

Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum.

Applications

Unspecified application

Species

Unspecified reactive species

Erick Sánchez-Salguero,Geovanni Kaleb Mondragón-Ramírez,Julio C Alcántara-Montiel,Arturo Cérbulo-Vázquez,Xóchitl Villegas-Domínguez,Víctor Manuel Contreras-Vargas,María Del Rocío Thompson-Bonilla,Héctor Romero-Ramírez,Leopoldo Santos-Argumedo

Oncology letters 16:3231-3240 PubMed30127919

2018

Identification of six serum antigens and autoantibodies for the detection of early stage epithelial ovarian carcinoma by bioinformatics analysis and liquid chip analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Yupeng Zou,Li Li

The Journal of clinical investigation 123:4809-20 PubMed24084741

2013

Extracellular hemin crisis triggers acute chest syndrome in sickle mice.

Applications

Unspecified application

Species

Unspecified reactive species

Samit Ghosh,Olufolake Adetoro Adisa,Prasanthi Chappa,Fang Tan,Kesmic Ann Jackson,David Robert Archer,Solomon Fiifi Ofori-Acquah
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com